Navigation Links
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
Date:5/9/2008

CALGARY, May 9 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has begun patient enrolment in a clinical trial using intravenous administration of REOLYSIN(R) in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers. The Principal Investigators are Dr. James Spicer of King's College in London, Dr. Johann de Bono and Dr. Kevin Harrington of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, and Professor Hardev Pandha of the Royal Surrey County Hospital NHS Trust, Surrey and Mount Alvernia Hospitals.

"We are hopeful that this trial will provide more information on how we might improve the effectiveness of this promising new approach to treating cancer," said Dr. Spicer.

"In animal models, pretreatment with low-dose immune modulators has been shown to significantly enhance the antitumour activity of REOLYSIN(R)(ref.)," added Dr. Brad Thompson, President and CEO of Oncolytics. "This study will help confirm if this can also be achieved in humans. If it can, it could lead to exciting opportunities to expand the use of REOLYSIN(R) for cancer treatment."

The trial (REO 012) is an open-label, dose-escalating, non-randomized trial of REOLYSIN(R) given intravenously with escalating doses of cyclophosphamide. A standard dose of REOLYSIN(R) is administered intravenously over five consecutive days, while an intravenous dose of cyclophosphamide is administered three days before REOLYSIN(R) treatment and continues through the course of the treatment cycle. The total number of patients studied will depend on the number of dose levels tested, but it is anticipated to be approximately 30 patients.

Eligible patients include those who have been diagnosed with advanced or metastatic solid tumours including pancreatic, lung and ovarian cancers that are refractory (have not responded) to sta
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting
2. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
3. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
4. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
5. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting
6. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting
7. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial
8. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
9. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
10. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
11. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 ...ill initiate water-soluble carbon nanotube-based c...e water-soluble carbon nanotubes, which have funct...ion with cancer drugs, was developed in partnershi...onjugated carbon nanotubes serves as a drug delive...
(Date:11/27/2009)... A mechanised blue dye test a...o packaging quality assurance one step closer for ...tact leak testing machine developed by Sepha f...installed in several local and global pharma-compa...dress quality assurance and productivity improveme...
(Date:11/25/2009)... , DURHAM, N.C., Nov. 25 ... the first energy-efficient, single-treatment wate...carbon nanotubes to Andhra Pradesh, Minister of Ru... leaders in Hyderabad, India today. Initial tests,... Kanpur, confirmed that the majority of the drinki...
(Date:11/25/2009)... Ambassador to Speak at Econom...to, Canada (Vocus) November 25, 2009 -- Ambassador...: ,David Appia, French Ambassador for Internationa...n France Agency ,To view a biography of David Appi...assador Appia is available to meet with press to d...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2
.../Xinhua-PRNewswire-FirstCall/ --,China Biologic Pr... "the,Company"), one of the leading plasma-based p...f China ("PRC"), today announced that the Company,...Drug Administration,("SFDA") (1) to start the prod...od product prepared from plasma and (2) to commenc...
...PRNewswire/ -- Today, Tigermed,Consulting Ltd. joi...in,their CRO Service Alliance CROSA that provides ...nies. Tigermed,s expertise in clinical,development...aceutical,development capabilities of the alliance...Sciences entered into a,CRO Service Alliance in Ma...
...FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ...cused on,endocrine therapy and oncology, today ann..., Chairman and CEO of Andros Men,s Health Institut...er Presentation in a Poster,Session at the 23rd An...h,was held March 26-28, 2008 in Milan, Italy. Titl...
Other Biology Technology:China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex 2China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex 3Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 2AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 3AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 4AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 5AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan 6
(Date:11/24/2009)...se is available in Spanish . , The presence...s of inflammatory substances in the blood, hinders... by a research project of the University of Navarr...st at the School of Pharmacy. , The project, ent...lation to the control of body weight and inflammat...
(Date:11/23/2009)...November 23, 2009 - The time of day matters to for... paper produced by a research team led by Professo...ugh,s vice-principal for research and colleagues i...e St. George campus. , Capitalizing on their p...ee, the research team examined how poplar trees us...
(Date:11/23/2009)..., Ill. A new study provides "incontrovertible evi... the island of Sumatra about 73,000 years ago defo...m the epicenter, researchers report. , The volca...h into the atmosphere, leaving a crater (now the w...rs long and 35 kilometers wide. Ash from the event...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2AirStrip Technologies Releases AirStrip OB for BlackBerry 54346 1AirStrip Technologies Releases AirStrip OB for BlackBerry 54346 2AirStrip Technologies Releases AirStrip OB for BlackBerry 54346 3Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 1Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 2Scientists Reverse Multiple Sclerosis in Mice 54342 1Scientists Reverse Multiple Sclerosis in Mice 54342 2
...are "breathing" far harder ?cycling the greenhouse...ized. , Most of the carbon being exhaled ?or outg... wetlands has spent a mere 5 years sequestered in ...ng landscape, U.S. and Brazilian researchers repor...ped that regions such as the nearly 2.4 million-sq...
...itical to the structure and function of cells and ...ir growing ends constantly elongate and retreat in...rization, like the writhing snakes of Medusa,s hai...s ongoing rapid growth and shrinkage is key to the...or the first time, researchers have revealed at mo...
...iseases (STDs) requires treatment of the sexual pa...t providing infected men with antibiotics to give ...means of contacting and treating the partners, acc...cal Infectious Diseases, now available online. Men...ee and talk to their female partners about the STD...
Other Biology News:Amazon source of 5-year-old river breath 2The making and breaking of microtubules 2The making and breaking of microtubules 3The making and breaking of microtubules 4The making and breaking of microtubules 5Measurement Challenges In Detecting Cancer Biomarkers 2Measurement Challenges In Detecting Cancer Biomarkers 3
...ional 4200A can be upgraded to the GenePix Autoloa...oads, scans, analyzes, and saves results for up to...tch is complete. Line-by-line autofocus ensures su...enePix Pro gives you complete flexibility to confi...
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
...of your microarray data using Asuragens bioinforma... consultation to extensive data analysis using the... combination with the Gene Expression Profiling Se...,Normalization and basic statistical analysis in...
Illumina Standard Data Analysis Report from Asuragen, Inc.
Biology Products: